Skip to main content
OpenTrials

Clinical trial condition

Heredodegenerative Disorders, Nervous System

Explore clinical trials studying Heredodegenerative Disorders, Nervous System. Study availability and eligibility vary by location and protocol.

1,879 public trials 409 recruiting studies
Refine in advanced search Browse all conditions

Heredodegenerative Disorders, Nervous System trial results

Completed

Neurology Measures in FA Children

NCT03418740

Conditions
Ataxia, Brain Diseases, Central Nervous System Diseases, +16 more
Locations
  • University of California, Los Angeles Los Angeles, California, United States
  • University of Florida Gainesville, Florida, United States
  • Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States
View Trial Details
Completed

Low-Dose or High-Dose Lenalidomide in Treating Younger Patients With Recurrent, Refractory, or Progressive Pilocytic Astrocytoma or Optic Pathway Glioma

NCT01553149

Conditions
Astrocytoma, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cranial Nerve Diseases, +31 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Phoenix Childrens Hospital Phoenix, Arizona, United States
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
View all 126 locations
View Trial Details
Completed

Study to Measure Cerebrospinal Fluid Mutant Huntingtin Protein in Participants With Early Manifest Stage I or Stage II Huntington's Disease

NCT03664804

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +14 more
Locations
  • CenExel Rocky Mountain Clinical Research, LLC Englewood, Colorado, United States
  • Georgetown University; Research Division, Psychiatry Washington D.C., District of Columbia, United States
  • Hereditary Neurological Disease Centre (HNDC) Wichita, Kansas, United States
  • John Hopkins University School of Medicine Baltimore, Maryland, United States
View all 15 locations
View Trial Details
Completed

Open-Label, Dose-Escalating Study Assessing Safety, Tolerability, Efficacy, of RP103 in Mitochondrial Disease

NCT02023866

Conditions
Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +40 more
Locations
  • University of California at San Diego (UCSD) San Diego, California, United States
  • Stanford University Stanford, California, United States
  • Akron Children's Hospital Akron, Ohio, United States
  • Baylor College of Medicine Houston, Texas, United States
View Trial Details

Related conditions